Table VII.
Multilevel regression model of EuroQol-5D-3L (EQ-5D-3L):* mean EQ-5D-3L estimates, and standard error of the mean (sem) over time by treatment group and group differences, with 95% confidence intervals (CI)
| Operative mean (sem) | Non-operative mean (sem) | Difference (95% CI) (operative – non-operative) | |
|---|---|---|---|
| Patients (n) | 123 | 121 | 244 |
| 3 mths | 0.61 (0.03) | 0.60 (0.03) | 0.01 ( -0.06 to 0.08) |
| 6 mths | 0.66 (0.03) | 0.63 (0.03) | 0.03 ( -0.04 to 0.10) |
| 12 mths | 0.63 (0.03) | 0.66 (0.03) | -0.02 ( -0.09 to 0.05) |
| 2 yrs | 0.66 (0.03) | 0.66 (0.03) | -0.00 (-0.08 to 0.07) |
| 3 yrs | 0.65 (0.03) | 0.63 (0.03) | 0.02 (-0.06 to 0.10) |
| 4 yrs | 0.67 (0.03) | 0.62 (0.04) | 0.05 (-0.04 to 0.14) |
| 5 yrs | 0.65 (0.04) | 0.62 (0.04) | 0.03 (-0.07 to 0.13) |
*multilevel model for EQ-5D-3L (score range 0 to 1, higher scores indicate better health related quality of life) adjusted for treatment allocation, time (three, six,12, 24, 36, 48 and 60 months), group-time interaction, baseline EQ-5D-3L index, gender, age group and tuberosity involvement at baseline (yes/no). Number of patients included in the analyses (complete baselines characteristics and EQ-5D-3L score for at least one follow-up)